Abstract | BACKGROUND & AIMS: METHODS: A database containing the medical records of more than 600 patients treated with 6-MP for IBD at 1 center between 1965 and 2002 was searched. The patients were divided into 2 groups. The study group consisted of patients who developed sustained leukopenia, defined as a white blood cell count of less than 4000 for 20 or more days. The control group patients matched those in the study group for age and sex. There were 3 matched controls for each patient in the study group. RESULTS: CONCLUSIONS: There was a trend toward a greater number of total malignancies in the sustained leukopenic patients. The data suggest that it is those patients who develop sustained leukopenia while taking 6-MP/ azathioprine who are most at risk.
|
Authors | William Disanti, Ramona O Rajapakse, Burton I Korelitz, Georgia Panagopoulos, Jason Bratcher |
Journal | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
(Clin Gastroenterol Hepatol)
Vol. 4
Issue 8
Pg. 1025-9
(Aug 2006)
ISSN: 1542-3565 [Print] United States |
PMID | 16765651
(Publication Type: Journal Article)
|
Chemical References |
- Immunosuppressive Agents
- Mercaptopurine
|
Topics |
- Adult
- Aged
- Case-Control Studies
- Databases as Topic
- Female
- Humans
- Immunosuppressive Agents
(administration & dosage, adverse effects)
- Incidence
- Inflammatory Bowel Diseases
(drug therapy)
- Leukopenia
(chemically induced)
- Male
- Mercaptopurine
(administration & dosage, adverse effects)
- Middle Aged
- Neoplasms
(etiology)
- Retrospective Studies
|